Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Sannala CKR"'
Autor:
Sannala CKR; Pumas-AI, Inc, Dover, DE, USA., MacLean C; Antev Ltd, London, UK., Larsen F; Antev Ltd, London, UK., van Os S; Antev Ltd, London, UK., Jadhav P; Vivpro Corp, Landsdale, PA, USA., Shore N; Carolina Urologic Research Center, Myrtle Beach, SC, USA., Morgans AK; Dana-Farber Cancer Institute, Boston, MA, USA., Okwuosa T; Rush University Medical Center, Chicago, IL, USA., Gobburu J; Pumas-AI, Inc, Dover, DE, USA.
Publikováno v:
Clinical pharmacology in drug development [Clin Pharmacol Drug Dev] 2024 Aug; Vol. 13 (8), pp. 915-929. Date of Electronic Publication: 2024 May 17.
Autor:
Sridharan K; Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India., Sannala CKR; GVK Biosciences Private Limited, Hyderabad, Telangana, India., Mallayasamy S; Department of Pharmacy Practice, Manipal College of Pharmaceutical Sciences, Manipal University, Manipal, Karnataka, India., Chaturvedula A; GVK Biosciences Private Limited, Hyderabad, Telangana, India., Kadam P; Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India., Hase N; Department of Nephrology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India., Shukla A; Department of Gastroenterology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India., Gogtay N; Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India., Thatte U; Department of Clinical Pharmacology, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra, India.
Publikováno v:
Indian journal of pharmacology [Indian J Pharmacol] 2019 Jan-Feb; Vol. 51 (1), pp. 17-24.